Showing 9061-9070 of 10530 results for "".
- Novartis Combination Therapy Tafinlar and Mekinist Receives FDA Priority Review Designationhttps://practicaldermatology.com/news/novartis-combination-therapy-tafinlar-and-mekinist-receive-fda-priority-review-designation/2458904/The FDA has granted priority review for the same patient population for the combination of Novartis’ Tafinlar® (dabrafenib) and Mekinist® (trametinib) for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation. Also, the Committee for Medi
- FDA Approves Odomzo for Locally Advanced BCChttps://practicaldermatology.com/news/fda-approves-odomzo-sonidegib-for-locally-advanced-bcc/2458903/The FDA approved Novartis’ Odomzo® (sonidegib, formerly LDE225) 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radi
- Dermatologist Warns of "Lime Disease"—Phytophotodermatosis—In Conjunction with National Tequila Dayhttps://practicaldermatology.com/news/dermatologist-warns-of-lime-diseasephytophotodermatosisin-conjunction-with-national-tequila-day/2458907/Margaritas may be the choice cocktail on July 24 to celebrate National Tequila Day, but Dr. Howard Steinman, a dermatologist with DermOne Dermatology Centers, has a sour warning: Sipping citrus fruit
- ASDS Finds Age Affects Facial Treatment Preferenceshttps://practicaldermatology.com/news/asds-finds-age-affects-facial-treatment-preferences/2458908/A research-based analysis published in Dermatologic Surgery found that facial treatment preferences among women often are tied to their age. Younger women are more likely to seek cosmetic medical treatments for the upper face while women 50 and older prioritize treatments of the lower fa
- CMS and AMA Announce Efforts to Ease ICD-10 Transitionhttps://practicaldermatology.com/news/cms-and-ama-announce-efforts-to-ease-icd-10-transition/2458913/The Centers for Medicare & Medicaid Services (CMS) and the American Medical Association (AMA) are initiating efforts to continue to help physicians get ready ahead of the October 1 deadline to move from ICD-9 to ICD-10 coding for medical diagnoses and inpatient hospital procedures. In respons
- ASDS: Laser Hair Removal On the Risehttps://practicaldermatology.com/news/asds-laser-hair-removal-on-the-rise/2458918/More patients are seeking laser treatments to permanently remove unwanted hair, a new American Society for Dermatologic Surgery (ASDS) survey shows. About 633,000 laser hair removal procedures were performed by ASDS members last year – a 27 percent increase from 2013 and a 51 percen
- David Dobrowski Named Vice President, Head of North American Research and Development at Merzhttps://practicaldermatology.com/news/david-dobrowski-named-vice-president-head-of-north-american-research-and-development-at-merz/2458921/Merz North American appointed David Dobrowski Vice President and Head of North American Research and Development, effective immediately. In this role, Mr. Dobrowski is responsible for all medical, regulatory, and product safety functions for Merz in North America. He leads the planning and execut
- National Psoriasis Foundation Awards Half a Million Dollars in Fellowshipshttps://practicaldermatology.com/news/national-psoriasis-foundation-awards-half-a-million-dollars-in-fellowships/2458922/Eleven early-career physicians each received a one-year, $50,000 National Psoriasis Foundation Medical Dermatology Fellowship to study psoriasis and psoriatic arthritis. These fellowships will help increase the number of scientists studying
- BTL Vanquish FDA Cleared for Circumferential Reduction of Abdomen Areahttps://practicaldermatology.com/news/btl-vanquish-fda-cleared-for-circumferential-reduction-of-abdomen-area/2458926/BTL Industries received FDA clearance of its BTL Vanquish device for circumferential reduction of the abdomen area. BTL Vanquish uses a panel array that emits selective RF energy with the largest spot size in the industry t
- Research Identifies Gene Linked to Melanoma Growth, Worse Outcomeshttps://practicaldermatology.com/news/research-identify-gene-linked-to-melanoma-growth-worse-outcomes/2458925/High levels of a specific protein linked to gene expression are associated with worse outcomes in melanoma, according to a study led by researchers at Icahn School of Medicine at Mount Sinai and published online in the journal Molecular Cell. Research shows that the protein, called H2A.Z.